EXPRESSION OF THE EXTRACELLULAR-MATRIX MOLECULE THROMBOSPONDIN INVERSELY CORRELATES WITH MALIGNANT PROGRESSION IN MELANOMA, LUNG AND BREAST-CARCINOMA CELL-LINES

被引:202
作者
ZABRENETZKY, V
HARRIS, CC
STEEG, PS
ROBERTS, DD
机构
[1] NCI,PATHOL LAB,BETHESDA,MD 20892
[2] NCI,HUMAN CARCINOGENESIS LAB,BETHESDA,MD 20892
关键词
D O I
10.1002/ijc.2910590209
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thrombospondin (TSP) is a member of a family of extracellular matrix glycoproteins that may participate in multiple aspects of the metastatic cascade. We report an inverse correlation of steady-state Thbs-1 mRNA and protein expression with malignant progression among murine melanoma and human lung and breast carcinoma cell lines. Murine K-1735 melanoma cell lines of low metastatic potential, including K-1735 lines transfected with the murine nm23-1 cDNA, expressed higher TSP levels than related highly metastatic lines. In a model system of lung carcinoma malignant progression, immortalized human branchial epithelial cells expressed higher TSP levels than v-Ki-ras, v-Ha-ras or n-ras transfectants, which in turn expressed higher TSP levels than tumor-derived, more aggressive variants. Among 3 unrelated breast carcinoma cell lines, Thbs-1 steady-state mRNA levels were greater in the 2 nonmetastatic lines than the metastatic line. Our data show that malignant progression in some cell lines is associated with reduced TSP expression. The suppressive effects of nm23-1 transfection an metastatic potential are also associated with increased TSP expression; ras transfection, which results in increased tumorigenesis, is associated with decreased TSP expression. (C) 1994 Wiley-Liss, Inc.*
引用
收藏
页码:191 / 195
页数:5
相关论文
共 22 条
  • [1] EXTRACELLULAR-MATRIX - THE THROMBOSPONDIN FAMILY
    ADAMS, J
    LAWLER, J
    [J]. CURRENT BIOLOGY, 1993, 3 (03) : 188 - 190
  • [2] ALBELDA SM, 1993, LAB INVEST, V68, P4
  • [3] INVASIVE AND METASTATIC POTENTIAL OF A V-HA-RAS-TRANSFORMED HUMAN BRONCHIAL EPITHELIAL-CELL LINE
    BONFIL, RD
    REDDEL, RR
    URA, H
    REICH, R
    FRIDMAN, R
    HARRIS, CC
    KLEINSZANTO, AJP
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (08): : 587 - 594
  • [4] THROMBOSPONDINS - STRUCTURE AND REGULATION OF EXPRESSION
    BORNSTEIN, P
    [J]. FASEB JOURNAL, 1992, 6 (14) : 3290 - 3299
  • [5] ANTISENSE-MEDIATED REDUCTION IN THROMBOSPONDIN REVERSES THE MALIGNANT PHENOTYPE OF A HUMAN SQUAMOUS CARCINOMA
    CASTLE, V
    VARANI, J
    FLIGIEL, S
    PROCHOWNIK, EV
    DIXIT, V
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) : 1883 - 1888
  • [6] CASTLE VP, 1993, J BIOL CHEM, V268, P2899
  • [7] CLEZARDIN P, 1993, CANCER RES, V53, P1421
  • [8] FRAZIER WA, 1993, THROMBOSPONDIN, P91
  • [9] THROMBOSPONDIN IS A SLOW TIGHT-BINDING INHIBITOR OF PLASMIN
    HOGG, PJ
    STENFLO, J
    MOSHER, DF
    [J]. BIOCHEMISTRY, 1992, 31 (01) : 265 - 269
  • [10] A NOVEL METHOD FOR SELECTION OF INVASIVE TUMOR-CELLS - DERIVATION AND CHARACTERIZATION OF HIGHLY METASTATIC K1735 MELANOMA CELL-LINES BASED ON INVITRO AND INVIVO INVASIVE CAPACITY
    KALEBIC, T
    WILLIAMS, JE
    TALMADGE, JE
    KAOSHAN, CS
    KRAVITZ, B
    LOCKLEAR, K
    SIEGAL, GP
    LIOTTA, LA
    SOBEL, ME
    STEEG, PS
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1988, 6 (04) : 301 - 318